Objectives

1. Clinical Design Guidelines for Device Based Therapies For treatment of Hypertension.
2. Review Renal Denervation for Hypertension:  What Have We Have We Learned from Randomized Clinical Trials (RCT).
3. Advances In Remote Clinical Management Of hypertension Patients.

Naomi Deirdre Fisher, MD, presenter, has  relevant financial relationships to disclose.

Faculty does  plan on discussing unlabeled/investigational uses of a commercial product.   

1. renal denervation, approved in Europe but not yet in the US. It is not yet a commercial product in the US.1
2.  a cuffless BP measuring device, approved in Europe but not yet in the US.  It is not yet a commercial product in the US.